Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [7838]

TAR-200 monotherapy shows greater than 80% complete response rate in patients with high-risk non-muscle-invasive bladder cancer

TAR-200 monotherapy shows greater than 80% complete response rate in patients with high-risk non-muscle-invasive...

AI predicts tumour-killing cells with high accuracy

AI predicts tumour-killing cells with high accuracy

Repurposed cancer drug could treat diabetes by nudging pancreatic acinar cells to produce insulin

Repurposed cancer drug could treat diabetes by nudging pancreatic acinar cells to produce insulin

Simulated chemistry: New AI platform designs tomorrow’s cancer drugs

Simulated chemistry: New AI platform designs tomorrow’s cancer drugs

Scientists track ‘doubling’ in origin of cancer cells

Scientists track ‘doubling’ in origin of cancer cells

Pancreatic cancer is difficult to treat. Nano-drugs hitching a ride on bacteria could help

Pancreatic cancer is difficult to treat. Nano-drugs hitching a ride on bacteria could help

Unraveling the roles of non-coding DNA explains childhood cancer’s resistance to chemotherapy

Unraveling the roles of non-coding DNA explains childhood cancer’s resistance to chemotherapy

New mRNA cancer vaccine triggers fierce immune response to fight malignant brain tumour

New mRNA cancer vaccine triggers fierce immune response to fight malignant brain tumour

Study indicates that cancer patients gain important benefits from genome-matched treatments

Study indicates that cancer patients gain important benefits from genome-matched treatments

Cancer centre adding cellular therapy to its arsenal against metastatic melanoma

Cancer centre adding cellular therapy to its arsenal against metastatic melanoma

More from ecancer